Mariko Kanai

Mariko Kanai

Auto-generated profile, based on publicly available information

Mariko Kanai

Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2018 in Journal of Immunology and Regenerative Medicine
Verified
Journal Article
Closed access
HWHolly M. Wobma
Holly M. Wobma
MKMariko Kanai
Mariko Kanai
SMStephen P. Ma
Stephen P. Ma
YSYing Shih
Ying Shih
HLHao Wei Li
Hao Wei Li
Gordana Vunjak-NovakovicGordana Vunjak-Novakovic
Gordana Vunjak-Novakovic

10 November 2023 in Science Advances
Verified
Journal Article
Open access
SMSachel Mok
Sachel Mok
TYTomas Yeo
Tomas Yeo
DHDavin Hong
Davin Hong
MSMelanie J. Shears
Melanie J. Shears
LRLeila S. Ross
Leila S. Ross
DFDavid A. Fidock
David A. Fidock
Drug-resistant Plasmodium falciparum parasites have swept across Southeast Asia and now threaten Africa. By implementing a P. falciparum genetic cross using humanized mice, we report the identification of key determinants of resistance to artemisinin (ART) and piperaquine (PPQ) in the dominant Asian KEL1/PLA1 lineage. We mapped k13 as the central mediator of ART resistance in vitro and identified secondary markers. Applying bulk segregant analysis, quantitative trait loci mapping using 34 recombinant haplotypes, and gene editing, our data reveal an epistatic interaction between mutant PfCRT and multicopy plasmepsins 2/3 in mediating high-grade PPQ resistance. Susceptibility and parasite fitness assays implicate PPQ as a driver of selection for KEL1/PLA1 parasites. Mutant PfCRT enhanced susceptibility to lumefantrine, the first-line partner drug in Africa, highlighting a potential benefit of opposing selective pressures with this drug and PPQ. We also identified that the ABCI3 transporter can operate in concert with PfCRT and plasmepsins 2/3 in mediating multigenic resistance to antimalarial agents.

18 January 2022 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
MKMariko Kanai
Mariko Kanai
TYTomas Yeo
Tomas Yeo
VAVictor Asua
Victor Asua
PRPhilip J. Rosenthal
Philip J. Rosenthal
DFDavid A. Fidock
David A. Fidock
SMSachel Mok
Sachel Mok
Research efforts to combat antimalarial drug resistance rely on quick, robust, and sensitive methods to genetically characterize Plasmodium falciparum parasites. We developed a single-nucleotide polymorphism (SNP)-based genotyping method that can assess 33 drug resistance-conferring SNPs in dhfr, dhps, pfmdr1, pfcrt, and k13 in nine PCRs, performed directly from P. falciparum cultures or infected blood.

18 July 2022 in Trends in Parasitology
Verified
Journal Article
Closed access
MKMariko Kanai
Mariko Kanai
LHLaura M. Hagenah
Laura M. Hagenah
EAElizabeth Ashley
Elizabeth Ashley
KCKelly Chibale
Kelly Chibale
DFDavid A. Fidock
David A. Fidock

6 July 2026 in Nature Microbiology
Verified
Journal Article
Open access
PDF file
MKMariko Kanai
Mariko Kanai
SMSachel Mok
Sachel Mok
TYTomas Yeo
Tomas Yeo
MSMelanie J. Shears
Melanie J. Shears
JJJin H. Jeon
Jin H. Jeon
DFDavid Armand Fidock
David Armand Fidock
The genetic basis of Plasmodium falciparum resistance to quinine, a drug used to treat severe malaria, has long been unclear. To investigate this, here we used a human liver-chimaeric mouse model to conduct a P. falciparum genetic cross between quinine-partially resistant and quinine-sensitive parasites. Drug profiling and quantitative trait loci analyses of 120 unique recombinant progeny mapped resistance to segments on chromosomes 7 and 12, indicating a polygenic basis. The chloroquine resistance transporter PfCRT and a structurally similar putative drug/metabolite transporter, DMT1, were identified as primary chromosome 7 candidates based on gene-editing studies. In a proteoliposome assay, both mutant DMT1 and PfCRT transported more quinine than their wild-type isoforms. DMT1 localized to the P. falciparum digestive vacuole, lipid bodies, parasitophorous vacuolar membrane and structures associated with vesicular trafficking. An ATP-dependent zinc metalloprotease (FtsH1) on chromosome 12 also modulated quinine and chloroquine resistance. We suggest that genotypic surveillance of these markers should be performed in clinical settings of quinine use.